Ikarian Capital »

Kazia Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Kazia Therapeutics (KZIA) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Kazia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kazia Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kazia Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.6M 396k 14.08

More positions owned by Ikarian Capital

Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals Call Option (IONS)
Kodiak Sciences (KOD)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Alumis (ALMS)
Praxis Precision Medicines I Com New (PRAX)
Moderna Put Option (MRNA)
Capricor Therapeutics Com New (CAPR)
Vaxcyte (PCVX)
Biosante Pharmaceuticals (ANIP)
Celldex Therapeutics Com New (CLDX)
Tenax Therapeutics Com New (TENX)
Vera Therapeutics Cl A (VERA)
Arcus Biosciences Incorporated (RCUS)
Relmada Therapeutics (RLMD)

View all positions for Ikarian Capital

Top funds holding Kazia Therapeutics

Boxer Capital Management
Putnam Fl Investment Management
Bleichroeder
Ikarian Capital
Dauntless Investment Group
Stonepine Capital Management
Susquehanna International
Point72 Asset Management
Ensign Peak Advisors
Citadel Advisors
Millennium Management
Jane Street
UBS Group
J. Goldman & Co
ADAR1 Capital Management

View all funds holding Kazia Therapeutics